JP2011219365A - Hyaluronidase inhibitor containing brown sugar extract and extract from red bean seed coat - Google Patents
Hyaluronidase inhibitor containing brown sugar extract and extract from red bean seed coat Download PDFInfo
- Publication number
- JP2011219365A JP2011219365A JP2010086456A JP2010086456A JP2011219365A JP 2011219365 A JP2011219365 A JP 2011219365A JP 2010086456 A JP2010086456 A JP 2010086456A JP 2010086456 A JP2010086456 A JP 2010086456A JP 2011219365 A JP2011219365 A JP 2011219365A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- brown sugar
- seed coat
- red bean
- hyaluronidase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000284 extract Substances 0.000 title claims abstract description 84
- 240000001417 Vigna umbellata Species 0.000 title claims abstract description 41
- 235000011453 Vigna umbellata Nutrition 0.000 title claims abstract description 41
- 229940122393 Hyaluronidase inhibitor Drugs 0.000 title claims abstract description 11
- 108010003272 Hyaluronate lyase Proteins 0.000 claims abstract description 34
- 102000001974 Hyaluronidases Human genes 0.000 claims abstract description 29
- 229960002773 hyaluronidase Drugs 0.000 claims abstract description 29
- 239000000203 mixture Substances 0.000 claims abstract description 27
- 239000002537 cosmetic Substances 0.000 claims abstract description 25
- 235000006089 Phaseolus angularis Nutrition 0.000 claims abstract description 8
- 240000007098 Vigna angularis Species 0.000 claims abstract description 8
- 235000010711 Vigna angularis Nutrition 0.000 claims abstract description 8
- 239000003112 inhibitor Substances 0.000 claims description 9
- 230000000694 effects Effects 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 239000003963 antioxidant agent Substances 0.000 claims description 5
- 230000003078 antioxidant effect Effects 0.000 claims description 4
- 230000002087 whitening effect Effects 0.000 claims description 4
- 229940123973 Oxygen scavenger Drugs 0.000 claims description 2
- 230000002401 inhibitory effect Effects 0.000 abstract description 15
- 230000037303 wrinkles Effects 0.000 abstract description 11
- 206010061218 Inflammation Diseases 0.000 abstract description 8
- 230000004054 inflammatory process Effects 0.000 abstract description 8
- 230000003203 everyday effect Effects 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 38
- 239000000243 solution Substances 0.000 description 20
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 239000000523 sample Substances 0.000 description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 13
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 11
- 229920002674 hyaluronan Polymers 0.000 description 11
- 229960003160 hyaluronic acid Drugs 0.000 description 11
- 238000007665 sagging Methods 0.000 description 11
- 210000003491 skin Anatomy 0.000 description 11
- 238000002835 absorbance Methods 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 238000000605 extraction Methods 0.000 description 8
- 239000012488 sample solution Substances 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 7
- 239000006071 cream Substances 0.000 description 7
- 239000000975 dye Substances 0.000 description 7
- 239000000049 pigment Substances 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 240000000111 Saccharum officinarum Species 0.000 description 6
- 235000007201 Saccharum officinarum Nutrition 0.000 description 6
- 239000008351 acetate buffer Substances 0.000 description 6
- 239000003463 adsorbent Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 241000609240 Ambelania acida Species 0.000 description 5
- 229960000583 acetic acid Drugs 0.000 description 5
- 239000010905 bagasse Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 239000006210 lotion Substances 0.000 description 5
- -1 pure ethanol Chemical compound 0.000 description 5
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 4
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- BGNGWHSBYQYVRX-UHFFFAOYSA-N 4-(dimethylamino)benzaldehyde Chemical compound CN(C)C1=CC=C(C=O)C=C1 BGNGWHSBYQYVRX-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 3
- 239000004327 boric acid Substances 0.000 description 3
- 229920001429 chelating resin Polymers 0.000 description 3
- 229920002055 compound 48/80 Polymers 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 244000235603 Acacia catechu Species 0.000 description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 2
- 229960003321 baicalin Drugs 0.000 description 2
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- IMZMKUWMOSJXDT-UHFFFAOYSA-N cromoglycic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C(O)=O)O2 IMZMKUWMOSJXDT-UHFFFAOYSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 239000003248 enzyme activator Substances 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 229960000905 indomethacin Drugs 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 1
- 235000006020 Acacia catechu Nutrition 0.000 description 1
- 244000005894 Albizia lebbeck Species 0.000 description 1
- 235000006226 Areca catechu Nutrition 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 244000105627 Cajanus indicus Species 0.000 description 1
- 235000010773 Cajanus indicus Nutrition 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Chemical group O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 1
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- PPWHTZKZQNXVAE-UHFFFAOYSA-N Tetracaine hydrochloride Chemical compound Cl.CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 PPWHTZKZQNXVAE-UHFFFAOYSA-N 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 240000000931 Uraria picta Species 0.000 description 1
- 241000219977 Vigna Species 0.000 description 1
- 235000010726 Vigna sinensis Nutrition 0.000 description 1
- GVBNSPFBYXGREE-CXWAGAITSA-N Visnadin Chemical compound C1=CC(=O)OC2=C1C=CC1=C2[C@@H](OC(C)=O)[C@@H](OC(=O)[C@H](C)CC)C(C)(C)O1 GVBNSPFBYXGREE-CXWAGAITSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000001560 acacia catechu Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical group O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 229940069765 bean extract Drugs 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229960000265 cromoglicic acid Drugs 0.000 description 1
- 229940109248 cromoglycate Drugs 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- 125000000600 disaccharide group Chemical group 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000000118 hair dye Substances 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 229940014041 hyaluronate Drugs 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000007934 lip balm Substances 0.000 description 1
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920005990 polystyrene resin Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Images
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
本発明は黒砂糖エキスと小豆(Vigna angularis)種皮抽出物を含有するヒアルロニダーゼ阻害剤及び化粧料組成物に係り、その目的は皮膚に潤いを与え、しわやたるみを改善、予防するとともに皮膚の炎症を抑え、しかも安全性に優れたヒアルロニダーゼ阻害剤及び化粧料組成物を提供することにある。 The present invention relates to a hyaluronidase inhibitor and cosmetic composition containing brown sugar extract and red bean (Vigna angularis) seed coat extract, the purpose of which is to moisturize the skin, improve and prevent wrinkles and sagging, and inflammation of the skin It is intended to provide a hyaluronidase inhibitor and a cosmetic composition excellent in safety.
ヒトの皮膚の老化の代表的な変化としてはしわやたるみが挙げられる。しわやたるみの形成は皮膚の弾力性の低下が原因であると考えられ、その要因の一つとして加齢、乾燥、酸化、紫外線等によるヒアルロン酸の減少を挙げることができる。
ヒアルロン酸はN−アセチルグルコサミンとグルクロン酸の二糖単位が連結した直鎖状の高分子多糖で分子量は100万以上になるといわれている。生体内では、関節、ガラス体、皮膚、脳等の広い範囲の細胞外マトリクスに存在する。
皮膚におけるヒアルロン酸には、細胞間隙に水を保持したり、組織内にゼリー状のマトリクスを形成して細胞を保持したりすることによって皮膚の潤滑性と柔軟性を保つとともに細菌感染を防止する機能があると考えられている。
従って、老化等に伴いヒアルロン酸分解酵素であるヒアルロニダーゼ活性が亢進すると、ヒアルロン酸が減少し皮膚の細胞の保水性が失われることにより柔軟性が損なわれ、しわやたるみの原因になり得る。
Typical changes in human skin aging include wrinkles and sagging. The formation of wrinkles and sagging is considered to be caused by a decrease in the elasticity of the skin, and one of the factors is a decrease in hyaluronic acid due to aging, drying, oxidation, ultraviolet rays and the like.
Hyaluronic acid is a linear high-molecular polysaccharide in which disaccharide units of N-acetylglucosamine and glucuronic acid are linked, and is said to have a molecular weight of 1 million or more. In vivo, it exists in a wide range of extracellular matrix such as joints, glass bodies, skin, and brain.
Hyaluronic acid in the skin retains the lubricity and flexibility of the skin and prevents bacterial infection by retaining water in the cell gap and forming cells in a jelly-like matrix in the tissue. It is considered functional.
Therefore, when hyaluronidase activity, which is a hyaluronic acid-degrading enzyme, increases with aging or the like, the hyaluronic acid is reduced and the water retention of skin cells is lost, so that flexibility may be lost and wrinkles and sagging may be caused.
一方、ヒアルロニダーゼは生体内に広く分布しておりヒアルロン酸を分解するとともに、炎症部位で活性の亢進が確認されているため起炎酵素としても知られている。
よってヒアルロニダーゼの阻害剤は、ヒアルロン酸が過剰に分解されることを防ぐことでヒアルロン酸の減少を抑制し、老化に伴うしわやたるみを改善、予防することができるとともに、炎症の抑制の面でも期待されている。
On the other hand, hyaluronidase is widely distributed in the living body and decomposes hyaluronic acid and is also known as a pro-inflammatory enzyme because it has been confirmed to have enhanced activity at the site of inflammation.
Therefore, the inhibitor of hyaluronidase can prevent the hyaluronic acid from being excessively decomposed, thereby suppressing the decrease in hyaluronic acid, improving and preventing wrinkles and sagging associated with aging, and also in terms of suppressing inflammation. Expected.
これまでグリチルリチン酸、クロモグリク酸ナトリウム、バイカリン、インドメタシン、アスピリン等に高いヒアルロニダーゼ活性阻害作用が確認され、これらは現在抗炎症剤として使用されている。しかしながら、グリチルリチン酸及びバイカリンは用途や使用濃度に制限があり、クロモグリク酸ナトリウムは妊婦に対しては厳重な使用上の注意を要する。さらに、インドメタシン及びアスピリンは、局所的な使用で発疹・痒み等の副作用が認められている等それぞれに問題がある。
このような問題点を克服するため、植物からヒアルロニダーゼ阻害活性を有する物質の探索も行われており、キイチゴ、ラカンカ、エンメイソウ、オトギリソウ、サルビアボダイジュ(特許文献1)やマメ科植物であるAcacia catechu(生薬名ペグ阿仙薬)、ビルマネムノキ(Albizia lebbeck)、ホソバフジグサ(Uraria picta)、Bauchinia forticata、Cajanus indicusの抽出物(特許文献2)にヒアルロニダーゼ阻害作用があることが報告されている。
しかし、これらは高価な生薬が原料であったり、入手が難しい植物を材料としているものであり、これらの植物の抽出物を日々使用する化粧品に使用するヒアルロニダーゼ阻害剤や化粧料組成物とするには高価なものとなりすぎるという問題点がある。
Until now, glycyrrhizic acid, cromoglycate sodium, baicalin, indomethacin, aspirin and the like have been confirmed to have high hyaluronidase activity inhibitory activity, and these are currently used as anti-inflammatory agents. However, glycyrrhizic acid and baicalin have limited usage and concentration, and sodium cromoglycate requires strict usage precautions for pregnant women. Furthermore, indomethacin and aspirin each have problems such as local side effects such as rash and itch have been observed.
In order to overcome such problems, a search for a substance having hyaluronidase inhibitory activity from plants has also been carried out. Acercia catechu (patent document 1) and leguminous plant Acacia catechu (patent document 1) It has been reported that extracts of herbal medicines (Peg Asen Yaku), Burbizane lebbeck, Uraria picta, Bauchinia forticata, and Cajanus indicus (Patent Document 2) have a hyaluronidase inhibitory action.
However, these are made from expensive herbal medicines or difficult-to-obtain plants. Hyaluronidase inhibitors and cosmetic compositions used in daily cosmetics are extracted from these plants. Has the problem of becoming too expensive.
本発明は上記問題点を解決するべくなされたものであって、安価で手に入りやすいサトウキビから製造される黒砂糖から抽出される黒砂糖エキス及び、現在廃棄物として処理されている小豆種皮から抽出した小豆種皮抽出物を混合するとヒアルロニダーゼ阻害作用が著しく上昇することを見出し、毎日使用する化粧料に含有することができる程度に安価でしかも安全性が高く、しわやたるみ及び炎症を改善、予防することができるヒアルロニダーゼ阻害剤及び化粧料組成物を提供することを課題とする。 The present invention has been made to solve the above-mentioned problems, from brown sugar extract extracted from brown sugar produced from sugarcane that is inexpensive and readily available, and red bean seed coat currently processed as waste. It is found that mixing the extracted red bean seed coat extract significantly increases the hyaluronidase inhibitory effect, and it is inexpensive and safe enough to be contained in daily cosmetics, improving and preventing wrinkles, sagging and inflammation. It is an object of the present invention to provide a hyaluronidase inhibitor and a cosmetic composition that can be used.
請求項1に係る発明は、黒砂糖エキスと小豆(Vigna angularis)種皮抽出物を含有することを特徴とするヒアルロニダーゼ阻害剤に関する。
請求項2に記載の発明は、請求項1に記載のヒアルロニダーゼ活性阻害剤を含有することを特徴とする化粧料組成物に関する。
請求項3に記載の発明は、さらに美白剤、活性酸素除去剤、抗酸化剤及び紫外線防止剤の中の一つ以上を含むことを特徴とする請求項2に記載の化粧料組成物に関する。
The invention according to claim 1 relates to a hyaluronidase inhibitor characterized by containing brown sugar extract and red bean (Vigna angularis) seed coat extract.
The invention according to claim 2 relates to a cosmetic composition comprising the hyaluronidase activity inhibitor according to claim 1.
The invention according to claim 3 further relates to the cosmetic composition according to claim 2, further comprising at least one of a whitening agent, an active oxygen removing agent, an antioxidant and an ultraviolet ray preventing agent.
請求項1及び2に係る発明によれば、黒砂糖エキスと小豆(Vigna angularis)種皮抽出物の混合物がヒアルロニダーゼを阻害することから、ヒアルロン酸の減少を抑制し、皮膚に潤いを保ってしわやたるみを改善、予防するとともに、炎症を抑制するヒアルロニダーゼ阻害剤及び化粧料組成物を提供することができる。
請求項3に係る発明よれば、黒砂糖エキスと小豆種皮抽出物に加えて美白剤、活性酸素除去剤、抗酸化剤及び紫外線防止剤の中の一つ以上を含むことによって、しわやたるみを改善、予防するとともに、皮膚を白く保ったり、活性酸素、酸化及び紫外線による皮膚の損傷を防ぐことができる化粧料組成物とすることができる。
According to the inventions according to claims 1 and 2, since the mixture of brown sugar extract and red bean (Vigna angularis) seed coat extract inhibits hyaluronidase, the reduction of hyaluronic acid is suppressed and the skin is kept moist and wrinkled. It is possible to provide a hyaluronidase inhibitor and a cosmetic composition that improve and prevent sagging and suppress inflammation.
According to the invention of claim 3, wrinkles and sagging are obtained by including one or more of a whitening agent, an active oxygen remover, an antioxidant and an ultraviolet light inhibitor in addition to the brown sugar extract and the red bean seed coat extract. While improving and preventing, it can be set as the cosmetic composition which can keep skin white, or can prevent the skin damage by active oxygen, oxidation, and ultraviolet rays.
本発明は、安価で手に入りやすい植物であるサトウキビから製造された黒砂糖から抽出される黒砂糖エキス及び廃棄物として処理されている小豆種皮からの抽出物を含有し、ヒアルロニダーゼを阻害してヒアルロン酸の分解を抑制することで皮膚に潤いを与え、しわやたるみを改善または予防するとともに炎症を抑え、しかも皮膚に対する安全性に優れたヒアルロニダーゼ阻害剤及び該ヒアルロニダーゼ阻害剤を含有する化粧料組成物である。 The present invention comprises a brown sugar extract extracted from brown sugar produced from sugarcane, which is an inexpensive and readily available plant, and an extract from red bean seed coat treated as waste, and inhibits hyaluronidase. Hyaluronic acid inhibitor that suppresses the degradation of hyaluronic acid, improves or prevents wrinkles and sagging, suppresses inflammation, and is excellent in safety to the skin, and a cosmetic composition containing the hyaluronidase inhibitor It is a thing.
黒砂糖エキスの抽出方法について説明する。
サトウキビは学名をSaccharum officinarumといいテンサイと並んで砂糖(蔗糖)の原料となる農作物である。栽培種の起源はニューギニア島とその近くの島々と言われ、世界各地の熱帯、亜熱帯地域で広く栽培される植物である。
サトウキビから原材料となる粗糖(蔗糖の未精製品)を準備調製し、この粗糖を適当量の水に溶解し、これを吸着剤に接触させて色素成分を吸着させ、水洗して糖分を充分に除去した後、吸着させた色素成分を溶剤により溶離させることにより抽出・分離する。
The extraction method of brown sugar extract is demonstrated.
Sugarcane is a crop that is used as a raw material for sugar (sucrose) along with sugar beet with the scientific name Saccharum officinarum. The origin of cultivated species is New Guinea Island and its nearby islands, and it is a plant that is widely cultivated in tropical and subtropical regions around the world.
Prepare and prepare raw sugar (raw sucrose) as raw material from sugarcane, dissolve this crude sugar in an appropriate amount of water, bring it into contact with an adsorbent, adsorb the pigment component, and wash it thoroughly with water. After removal, the adsorbed dye component is extracted and separated by eluting with a solvent.
通常この操作は吸着剤のカラムを用い、水又は溶剤を流下させて行う。吸着剤としては非極性のポリスチレン系吸着樹脂であれば限定されないが、例えばアンバーライトXAD−1、アンバーライトXAD−2(商品名、ローム・アンド・ハース社製)及びセルバクロムXAD−2(商品名、セルバ社製)が好適に用いられる。収率の点からはセルバクロムXAD−2が特に好ましい。また、吸着剤の使用量は含有色素成分量の30〜300倍(重量比)、より好ましくは50〜200倍(重量比)である。 Usually, this operation is carried out using an adsorbent column with water or solvent flowing down. The adsorbent is not limited as long as it is a nonpolar polystyrene-based adsorbent resin. For example, Amberlite XAD-1, Amberlite XAD-2 (trade name, manufactured by Rohm and Haas) and Selvachrome XAD-2 (trade name) (Manufactured by Selva) is preferably used. Selvachrome XAD-2 is particularly preferred from the viewpoint of yield. Further, the amount of the adsorbent used is 30 to 300 times (weight ratio), more preferably 50 to 200 times (weight ratio) of the amount of the contained pigment component.
吸着した色素成分を溶離させるに際して、溶離前に水洗して洗液の甘味が全くなくなるまで充分に糖分を除去させることが好ましい。糖分が残存することで化粧料にざらつきが出て、配合できる量が限られてしまうからである。 When the adsorbed dye component is eluted, it is preferable to remove the sugar sufficiently until the sweetness of the washing solution is completely eliminated by washing with water before elution. This is because the sugar remains and the amount of the sugar that can be blended is limited.
色素成分の溶離は濃度20重量%以上の低級アルコールであれば限定されない。低級アルコールとしてはメタノール又はエタノール、プロピルアルコール、イソプロピルアルコール、ブタノール、イソブタノール等を挙げることができるがメタノールまたはエタノールで行なうのが好適である。化粧料に用いても安全であり且つ抽出後に溶媒を除去しやすいからである。
実際には、まず20〜30重量%の低級アルコールで溶離を行い、流下液の着色が殆ど認められなくなった後、95〜99重量%の高濃度低級アルコールでさらに溶離させるのが好ましい。この理由は、低濃度低級アルコールのみで溶離を行なうと色素成分の収率が低下し、好ましくないからである。
The elution of the dye component is not limited as long as it is a lower alcohol having a concentration of 20% by weight or more. Examples of the lower alcohol include methanol or ethanol, propyl alcohol, isopropyl alcohol, butanol, isobutanol, etc., but methanol or ethanol is preferable. This is because it is safe to use in cosmetics and the solvent is easily removed after extraction.
Actually, it is preferable to first elute with 20 to 30% by weight of lower alcohol, and after further elution of the color of the flowing-down solution, it is preferable to further elute with 95 to 99% by weight of high-concentration lower alcohol. The reason for this is that elution with only a low-concentration lower alcohol is not preferable because the yield of the dye component decreases.
糖分の除去が不完全で、溶離液に甘味が残存する場合には、その蒸発残留物を純エタノール等の純低級アルコールに混合し、不溶の糖分を濾別し、除去し、濾液から色素成分を再結晶させることで純度の高い色素成分を得ることができる。 If sugar removal is incomplete and sweetness remains in the eluent, the evaporation residue is mixed with pure lower alcohol such as pure ethanol, insoluble sugar is filtered off and removed, and the pigment component is removed from the filtrate. By recrystallizing, a highly pure pigment component can be obtained.
また、前記色素成分を得る方法として、前記した方法以外に、粗黒糖をメタノール、純エタノール等の純低級アルコールに直接冷浸又は温浸し、不溶の糖分を濾過等の方法により除去した後、残液を蒸発乾固して色素成分を得る方法も使用することができる。このような粗黒糖の色素成分は、原料粗黒糖から0.05〜0.3重量%程度の収率で得ることができ、淡褐色の吸湿性の粉末で、僅かに焦臭があり、味は僅かに苦い粉末である。 Further, as a method for obtaining the dye component, in addition to the above-described method, the crude brown sugar is directly immersed or digested in pure lower alcohol such as methanol or pure ethanol, and the insoluble sugar content is removed by a method such as filtration. A method of obtaining a pigment component by evaporating the liquid to dryness can also be used. The pigment component of such crude brown sugar can be obtained from the raw crude brown sugar in a yield of about 0.05 to 0.3% by weight, is a light brown hygroscopic powder, has a slightly scorching smell, Is a slightly bitter powder.
このようにして得た溶離液(色素成分)を蒸発乾固した後、シリカゲルカラムで精製分離することで黒砂糖エキスを得ることができる。
尚、黒砂糖エキスとしてはコクトオリゴピュア(商品名、大阪薬品研究所製)を用いることもできる。
The eluate (pigment component) thus obtained is evaporated to dryness, and then purified and separated with a silica gel column to obtain a brown sugar extract.
In addition, as a brown sugar extract, Coct Oligo Pure (trade name, manufactured by Osaka Pharmaceutical Research Laboratories) can be used.
次に小豆種皮抽出物の抽出方法について説明する。
小豆は学名をVigna angularisといい、東アジア原産のマメ科ササゲ属の一年草である。通常は種子を食用とする。
本発明では市販の小豆を用いることができる。
Next, a method for extracting the red bean seed coat extract will be described.
The red bean is called Vigna angularis, and is an annual plant of the leguminous cowpea genus native to East Asia. Usually seeds are edible.
In the present invention, commercially available red beans can be used.
小豆を沸騰した湯に浸漬する。その後磨砕により種皮を分離し、分離した種皮は乾燥させて小豆種皮を得る。 Immerse the red beans in boiling water. Thereafter, the seed coat is separated by grinding, and the separated seed coat is dried to obtain a red bean seed coat.
得られた小豆種皮から小豆種皮抽出物を得る際に用いられる抽出溶媒は特に限定されず、水やアルコール等の親水性有機溶媒又はこれらの混液等を好適に用いることができる。親水性有機溶媒としてはメタノール又はエタノール、プロピルアルコール、イソプロピルアルコール、ブタノール、イソブタノール等を挙げることができるがエタノールで行なうのが好適である。
抽出方法としては冷浸法や温浸法を例示することができるがこれに限定されるものではない。
The extraction solvent used when obtaining the red bean seed coat extract from the obtained red bean seed coat is not particularly limited, and a hydrophilic organic solvent such as water or alcohol or a mixed solution thereof can be suitably used. Examples of the hydrophilic organic solvent include methanol or ethanol, propyl alcohol, isopropyl alcohol, butanol, isobutanol, etc., but ethanol is preferred.
Examples of the extraction method include a cold immersion method and a digestion method, but are not limited thereto.
抽出液はそのまま用いても構わないが、減圧下で濃縮乾固させるか凍結乾燥により抽出液を除去して乾燥物を小豆種皮抽出物として用いても良い。 The extract may be used as it is, but the extract may be concentrated to dryness under reduced pressure or the extract may be removed by lyophilization, and the dried product may be used as the red bean seed coat extract.
本発明に係る黒砂糖エキス及び小豆種皮抽出物の形態としては、液状、固形状、粉末状、ペースト状、ゲル状等のいずれの形状でもよく、配合する化粧品に含有させる上で最適な形態を任意に選択することができる。 The form of brown sugar extract and red bean seed coat extract according to the present invention may be any form such as liquid, solid, powder, paste, gel, etc., and the optimum form for inclusion in the cosmetics to be blended Can be arbitrarily selected.
本発明に係る黒砂糖エキス及び小豆種皮抽出物を配合する化粧品としては、化粧水、乳液、美容液、一般クリーム、クレンジングクリーム等の洗顔料、パック、髭剃り用クリーム、日焼けクリーム、日焼け止めクリーム、日焼けローション、日焼け止めローション、化粧石鹸、ファンデーション、おしろい、パウダー、口紅、リップクリーム、アイライナー、アイクリーム、アイシャドウ、マスカラ、浴用化粧品、シャンプー、リンス、染毛料、頭髪用化粧品等の各種化粧品に利用可能である。 Cosmetics containing the brown sugar extract and red bean seed coat extract according to the present invention include lotions, milky lotions, beauty essences, general creams, cleansing creams, facial cleansers, packs, shaving creams, sun creams, sunscreen creams , Suntan lotion, sunscreen lotion, cosmetic soap, foundation, funny, powder, lipstick, lip balm, eyeliner, eye cream, eye shadow, mascara, bath cosmetics, shampoo, rinse, hair dye, hair cosmetics, etc. Is available.
本発明に係る黒砂糖エキスと小豆種皮抽出物の配合割合は含有する化粧品によって任意に変更することができるが、黒砂糖エキス:小豆種皮抽出物を重量比1:1で配合することが好ましい。ヒアルロニダーゼの阻害作用が高いからである。 The blending ratio of the brown sugar extract and the red bean seed coat extract according to the present invention can be arbitrarily changed depending on the cosmetics to be contained, but it is preferable to blend the brown sugar extract: red bean seed coat extract at a weight ratio of 1: 1. This is because the inhibitory action of hyaluronidase is high.
本発明に係る黒砂糖エキス及び小豆種皮抽出物の配合量は0.001重量%〜0.5重量%が好ましく、より好ましくは0.001重量%〜0.1重量%である。0.001重量%未満の場合はヒアルロニダーゼの阻害作用が十分に発揮されず、また0.5重量%を超えて配合してもそれ以上の効果が望めずいずれの場合も好ましくないからである。 The blending amount of the brown sugar extract and red bean seed coat extract according to the present invention is preferably 0.001% to 0.5% by weight, and more preferably 0.001% to 0.1% by weight. When the amount is less than 0.001% by weight, the inhibitory action of hyaluronidase is not sufficiently exhibited, and even if the amount exceeds 0.5% by weight, no further effect can be expected, which is not preferable in any case.
本発明に係る化粧料組成物は黒砂糖エキス及び小豆種皮抽出物に加えて、美白剤、活性酸素除去剤、抗酸化剤、紫外線防止剤を含有することができる。 The cosmetic composition according to the present invention may contain a whitening agent, an active oxygen remover, an antioxidant, and an ultraviolet ray inhibitor in addition to the brown sugar extract and the red bean seed coat extract.
美白剤としてはビタミンC類及びその誘導体、ハイドロキノン及びその誘導体、システイン及びその誘導体、グラブリジン、グラブレン、リクイリチン、イソリクイリチン等を例示することができる。 Examples of whitening agents include vitamin Cs and derivatives thereof, hydroquinone and derivatives thereof, cysteine and derivatives thereof, grabrizine, grabrene, liquiritin, and isoquiritin.
活性酸素除去剤としては、マンニトール、βカロチン、アスタキサンチン、ルチン及びその誘導体を例示することができる。 Examples of the active oxygen scavenger include mannitol, β-carotene, astaxanthin, rutin and derivatives thereof.
抗酸化剤としては、ビタミンE及びその誘導体、ジブチルヒドロキシトルエンを例示することができる。 Examples of antioxidants include vitamin E and its derivatives, dibutylhydroxytoluene.
紫外線防止剤としてはサリチル酸ホモメンチル、4−メトキシケイ皮酸−2−エチルヘキシル、2−ヒドロキシ−4−メトキシベンゾフェノン、2−ヒドロキシ−4−メトキシベンゾフェノンスルホン酸、2−ヒドロキシ−4−メトキシベンゾフェノンスルホン酸ナトリウム、4−t−ブチル−4’−メトキシ−ジベンゾイルメタン、酸化チタン、酸化亜鉛、酸化セリウムを例示することができる。 As UV inhibitors, homomenthyl salicylate, 2-methoxyhexycin 2-ethylhexyl, 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxybenzophenonesulfonic acid, sodium 2-hydroxy-4-methoxybenzophenonesulfonate 4-t-butyl-4′-methoxy-dibenzoylmethane, titanium oxide, zinc oxide, cerium oxide.
以下実施例に基づき本発明を詳細に説明するが、本発明は以下の実施例に限定されるものではない。 EXAMPLES Hereinafter, although this invention is demonstrated in detail based on an Example, this invention is not limited to a following example.
<ヒアルロニダーゼ阻害活性測定方法>
ヒアルロニダーゼ阻害活性を調べる試料液は以下のように調製した。
<Method for measuring hyaluronidase inhibitory activity>
A sample solution for examining hyaluronidase inhibitory activity was prepared as follows.
(試料の調製)
(黒砂糖エキス)
沖縄産黒砂糖5kgを水25Lに溶解し、ポリスチレン系樹脂(アンバーライトXAD,2500g)を水1Lに分散させて充填した内径8cmのカラムに注入し、20mL/分の速度で流下させ、黒砂糖の色素成分を吸着させた。次に、水を流下させ甘味の全くなくなるまで水洗して充分に糖分を除き、20%メタノールを注入し、10mL/分の速度で流下させ、吸着剤から色素を溶離させた。流下液に着色がなくなるまで流下を続け、流出液を混合して60℃以下で減圧蒸発乾固し、甘味の全くない褐色残留物約16gを得た。これを2Lの純エタノールに溶解した後加熱し、冷却後、析出した濁り物質を濾別し、60℃以下で減圧濃縮し、その残留物を60℃以下で乾燥して甘味の全くない褐色粉末を得た。得られた褐色粉末をさらにシリカゲルクロマトグラフィで精製、分離して黒砂糖エキスを得た。
(Sample preparation)
(Brown sugar extract)
5 kg of Okinawan brown sugar is dissolved in 25 L of water, poured into a column with an inner diameter of 8 cm, in which polystyrene resin (Amberlite XAD, 2500 g) is dispersed and packed in 1 L of water, and allowed to flow down at a rate of 20 mL / min. The dye component was adsorbed. Next, water was allowed to flow down and washed with water until there was no sweetness, the sugar content was sufficiently removed, 20% methanol was injected, and flowed down at a rate of 10 mL / min to elute the dye from the adsorbent. The flow-down was continued until no color was observed, and the effluent was mixed and evaporated to dryness under reduced pressure at 60 ° C. or lower to obtain about 16 g of brown residue having no sweetness. This was dissolved in 2 L of pure ethanol, heated, cooled, and the precipitated turbid material was filtered off and concentrated under reduced pressure at 60 ° C. or lower, and the residue was dried at 60 ° C. or lower to give a brown powder having no sweetness. Got. The obtained brown powder was further purified and separated by silica gel chromatography to obtain a brown sugar extract.
(小豆種皮抽出物)
小豆を水で洗浄した後、沸騰した湯に約10分間浸漬する。その後磨砕することによって小豆種皮を分離し乾燥させた。
乾燥した小豆種皮100gについて、30重量%エタノール水溶液500gを用いて40℃で2時間浸漬した後、濾過をして1度目の抽出液を得た。1度目の抽出操作後の小豆種皮に対して同じ抽出操作を行い2度目の抽出液を得た。1度目と2度目の抽出液を合わせ、減圧下で濃縮乾固もしくは凍結乾燥によってエタノール及び水を除去し、得られた固形物12.7gを小豆種皮抽出物とした。
(Azuki bean seed extract)
After washing the beans with water, immerse them in boiling water for about 10 minutes. Thereafter, the red bean seed coat was separated and dried by grinding.
100 g of dried red bean seed coat was immersed in 500 g of a 30 wt% aqueous ethanol solution at 40 ° C. for 2 hours, followed by filtration to obtain a first extract. The same extraction operation was performed on the red bean seed coat after the first extraction operation to obtain a second extract. The first and second extracts were combined, ethanol and water were removed by concentration to dryness or lyophilization under reduced pressure, and 12.7 g of the resulting solid was used as an adzuki bean seed coat extract.
(バガス抽出物)
サトウキビ圧搾後の残渣を乾燥したバガス100gについて、50重量%含水エタノール2Lを用いて55℃で2時間抽出後、濾過をして1度目の抽出液を得た。1度目の抽出操作後のバガス残渣について、同条件にて抽出操作を行い、2度目の抽出液を得た。1度目と2度目の抽出液を合わせ、減圧下で濃縮乾固もしくは凍結乾燥によってエタノール及び水を除去し、得られた固形物5.98gをバガス抽出物とした。
(Bagasse extract)
About 100 g of bagasse dried from the residue after pressing the sugarcane, 2 L of 50 wt% ethanol was extracted at 55 ° C. for 2 hours, followed by filtration to obtain a first extract. The bagasse residue after the first extraction operation was subjected to the extraction operation under the same conditions to obtain a second extract. The first and second extracts were combined, ethanol and water were removed by concentration to dryness or lyophilization under reduced pressure, and 5.98 g of the resulting solid was used as a bagasse extract.
(ジオウ抽出物)
ジオウ抽出物は日本粉末薬品株式会社製、ジオウ乾燥エキスを用いた。
(Geo extract)
As the Ziou extract, Nippon Ziyu Pharmaceutical Co., Ltd., Ziou dry extract was used.
(試料液の調製)
試料を2mg秤量し、2mlの適切な溶媒に溶解し、1mg/mLとなるように調製した。試料を溶解する溶媒は蒸留水を用いたが、試料が溶解しなければ10%DMSO水溶液または10%メタノール水溶液に溶解し使用した。
使用時にはこの溶液を夫々の物質の最終濃度が200ppm、600ppm、1000ppmとなるように希釈して用いた。つまり、黒砂糖エキス+小豆種皮抽出物が200ppmと記載した場合は黒砂糖エキスの最終濃度が200ppmかつ小豆抽出物の最終濃度が200ppmであることを表わしている。
(Preparation of sample solution)
2 mg of the sample was weighed and dissolved in 2 ml of an appropriate solvent to prepare 1 mg / mL. Distilled water was used as a solvent for dissolving the sample, but if the sample did not dissolve, it was dissolved in 10% DMSO aqueous solution or 10% methanol aqueous solution and used.
At the time of use, this solution was used by diluting so that the final concentrations of the respective substances were 200 ppm, 600 ppm and 1000 ppm. That is, when the brown sugar extract + red bean seed coat extract is described as 200 ppm, it indicates that the final concentration of the brown sugar extract is 200 ppm and the final concentration of the red bean extract is 200 ppm.
試料液は以下の4種類である。
試料液(1)黒砂糖エキス
試料液(2)黒砂糖エキス+バガス抽出物
試料液(3)黒砂糖エキス+ジオウ抽出物
試料液(4)黒砂糖エキス+小豆種皮抽出物
There are the following four types of sample solutions.
Sample liquid (1) Brown sugar extract sample liquid (2) Brown sugar extract + bagasse extract sample liquid (3) Brown sugar extract + Diou extract sample liquid (4) Brown sugar extract + red bean seed coat extract
ヒアルロニダーゼ阻害活性測定に用いる試薬は以下のようにして調整した。 The reagent used for measuring the hyaluronidase inhibitory activity was prepared as follows.
(試薬の調製)
(0.1M酢酸緩衝液(pH4.0))
0.2M酢酸ナトリウム溶液を0.2M酢酸に82:18の体積比で混合し、さらに2倍に希釈して調製した。
(酵素ヒアルロニダーゼ溶液)
ヒアルロニダーゼ(Type−4S from Bovine Testes、シグマ社製)を6mg秤量し、1.5mlの0.1M酢酸緩衝液(pH4.0)に溶解し4mg/ml(最終濃度0.8mg/ml)となるように調製した。
(酵素活性化剤Compound48/80)
Compound48/80(シグマ社製)を2.5mg秤量し、5mlの0.1M酢酸緩衝液(pH4.0)に溶解し、0.5mg/ml(最終濃度0.1mg/ml)となるように調製した。
(基質ヒアルロン酸ナトリウム溶液)
ヒアルロン酸ナトリウムを10mg秤量し、12.5mlの0.1M酢酸緩衝液(pH4.0)に溶解し、0.8mg/ml(最終濃度0.16mg/ml)となるように調製した。
(p−ジメチルアミノベンズアルデヒド溶液)
p−ジメチルアミノベンズアルデヒド5gを10N塩酸6mlと酢酸44mlに溶解し調製した。使用時にはこの溶液を氷酢酸で10倍希釈して用いた。
(1Mホウ酸溶液)
61.83gのホウ酸(和光純薬製)を蒸留水に溶解して1Lに定溶して調製した。
(Preparation of reagents)
(0.1 M acetate buffer (pH 4.0))
A 0.2 M sodium acetate solution was mixed with 0.2 M acetic acid at a volume ratio of 82:18, and further diluted 2 times.
(Enzyme hyaluronidase solution)
6 mg of hyaluronidase (Type-4S from Bovine Tests, manufactured by Sigma) is weighed and dissolved in 1.5 ml of 0.1 M acetate buffer (pH 4.0) to 4 mg / ml (final concentration 0.8 mg / ml). It was prepared as follows.
(Enzyme Activator Compound 48/80)
Compound 48/80 (manufactured by Sigma) was weighed 2.5 mg and dissolved in 5 ml of 0.1 M acetate buffer (pH 4.0) to a final concentration of 0.5 mg / ml (final concentration 0.1 mg / ml). Prepared.
(Substrate hyaluronate solution)
10 mg of sodium hyaluronate was weighed and dissolved in 12.5 ml of 0.1 M acetate buffer (pH 4.0) to prepare 0.8 mg / ml (final concentration 0.16 mg / ml).
(P-dimethylaminobenzaldehyde solution)
5 g of p-dimethylaminobenzaldehyde was dissolved in 6 ml of 10N hydrochloric acid and 44 ml of acetic acid to prepare. In use, this solution was diluted 10-fold with glacial acetic acid.
(1M boric acid solution)
61.83 g of boric acid (manufactured by Wako Pure Chemical Industries, Ltd.) was dissolved in distilled water and dissolved in 1 L.
(測定方法)
試験管に試料液を100μl加え、さらに酵素ヒアルロニダーゼ溶液を50μL加え、37℃で20分インキュベートした。その後酵素活性化剤Compound48/80溶液を100μL加えてから、37℃、20分間さらにインキュベートし、基質ヒアルロン酸ナトリウム溶液を250μL加え、アルミキャップをして37℃で40分間反応させた。
0.4N水酸化ナトリウム溶液100μLを加えて反応を停止させた後、1Mホウ酸溶液を100μL添加して3分間煮沸処理をした。反応液を室温まで冷却した後、氷酢酸で10倍希釈したp−ジメチルアミノベンズアルデヒド溶液を3mL添加し、再度37℃、20分間インキュベートした後、マイクロプレートに移し、585nmにおける吸光度をマイクロプレートリーダー(Bio−Rad社製)で測定した。
コントロールとして、酵素ヒアルロニダーゼ溶液の代わりに0.1M酢酸緩衝液(pH4.0)を添加したもの、試料液の代わりに試料溶媒を添加したものを同様に処理し、吸光度を測定した。
ポジティブコントロールとしてはヒアルロニダーゼ阻害活性を有するグリチルリチン酸二カリウムを0.5mg/mL(最終濃度100ppm)の濃度で用いた。
得られた結果は次式に従ってヒアルロニダーゼ阻害率を算出した。
(式)
阻害率(%)=(1−(S−SB)/(C−CB))×100
S:試料液を加えた時の吸光度(試験吸光度)
SB:酵素ヒアルロニダーゼ溶液の代わりに0.1M酢酸緩衝液(pH4.0)を添加した時の吸光度(試料吸光度)
C:試料液の代わりに試料を溶解した溶媒を加えた時の吸光度(最大吸光度)
CB:酵素ヒアルロニダーゼ溶液の代わりに0.1M酢酸緩衝液(pH4.0)を加え、試料液の代わりに試料を溶解した溶媒を加えた時の吸光度(試料溶媒吸光度)
(Measuring method)
100 μl of the sample solution was added to the test tube, 50 μL of the enzyme hyaluronidase solution was further added, and the mixture was incubated at 37 ° C. for 20 minutes. Thereafter, 100 μL of the enzyme activator Compound 48/80 solution was added, and further incubated at 37 ° C. for 20 minutes, 250 μL of the substrate sodium hyaluronate solution was added, the aluminum cap was applied, and the mixture was reacted at 37 ° C. for 40 minutes.
After stopping the reaction by adding 100 μL of 0.4N sodium hydroxide solution, 100 μL of 1M boric acid solution was added and boiling treatment was performed for 3 minutes. After cooling the reaction solution to room temperature, 3 mL of a p-dimethylaminobenzaldehyde solution diluted 10-fold with glacial acetic acid was added, incubated again at 37 ° C. for 20 minutes, transferred to a microplate, and the absorbance at 585 nm was measured using a microplate reader ( Bio-Rad).
As a control, a sample added with 0.1 M acetate buffer (pH 4.0) instead of the enzyme hyaluronidase solution and a sample solvent added instead of the sample solution were treated in the same manner, and the absorbance was measured.
As a positive control, dipotassium glycyrrhizinate having hyaluronidase inhibitory activity was used at a concentration of 0.5 mg / mL (
As a result, the hyaluronidase inhibition rate was calculated according to the following formula.
(formula)
Inhibition rate (%) = (1− (S−SB) / (C−CB)) × 100
S: Absorbance when the sample solution is added (test absorbance)
SB: Absorbance (sample absorbance) when 0.1 M acetate buffer (pH 4.0) was added instead of the enzyme hyaluronidase solution
C: Absorbance when the solvent in which the sample is dissolved is added instead of the sample solution (maximum absorbance)
CB: Absorbance when 0.1M acetic acid buffer (pH 4.0) is added instead of the enzyme hyaluronidase solution and the solvent in which the sample is dissolved is added instead of the sample solution (sample solvent absorbance)
(結果)
結果を図1に示す。
黒砂糖エキスのみを添加した場合は1000ppm添加した場合であってもヒアルロニダーゼ阻害作用を示さなかったのに対して、黒砂糖エキス1000ppm及び小豆種皮抽出物1000ppmを添加した場合はヒアルロニダーゼを70%以上阻害することが確認された。
次に小豆種皮抽出物のみのヒアルロニダーゼ阻害作用について調べたところ1000ppm添加した時であっても阻害率は30%程度であった(図2参照)。
以上の結果より本発明に係る黒砂糖エキス及び小豆種皮抽出物の混合物はそれぞれ単独で添加した場合に比べてヒアルロニダーゼ阻害作用が増大したため、黒砂糖エキスと小豆種皮抽出物の組み合わせはヒアルロニダーゼ阻害作用に関して相乗効果があることが示された。
(result)
The results are shown in FIG.
When only brown sugar extract was added, even when 1000 ppm was added, it did not show hyaluronidase inhibitory action, whereas when
Next, when the hyaluronidase inhibitory action of only the red bean seed coat extract was examined, the inhibition rate was about 30% even when 1000 ppm was added (see FIG. 2).
From the above results, the mixture of brown sugar extract and red bean seed coat extract according to the present invention has increased hyaluronidase inhibitory action compared to the case where each was added alone, so the combination of brown sugar extract and red bean seed coat extract is related to the hyaluronidase inhibitory action. It was shown that there is a synergistic effect.
従って黒砂糖エキスと小豆種皮抽出物を含有する組成物は、ヒアルロニダーゼを阻害してヒアルロン酸を分解しにくくするため、皮膚に潤いを与え、しわやたるみを改善、予防するとともに炎症を抑える効果があるといえる。 Therefore, the composition containing brown sugar extract and red bean seed coat extract inhibits hyaluronidase and makes it difficult to break down hyaluronic acid, thus moisturizing the skin, improving and preventing wrinkles and sagging and suppressing inflammation. It can be said that there is.
以下に黒砂糖エキスと小豆種皮抽出物を配合した化粧品の処方例及び製造方法を示す。 The formulation example and manufacturing method of the cosmetics which mix | blended the brown sugar extract and the red bean seed coat extract are shown below.
(処方例1)クリーム
A、B共に80℃で加温溶解し、Aをホモミキサーで攪拌しながらBを徐々に加えて乳化する。攪拌を続けながら冷却し、40℃になったところでCを加え、約35℃で調製を終了する。
(Formulation Example 1) Cream
Both A and B are heated and dissolved at 80 ° C., and B is gradually added and emulsified while A is stirred with a homomixer. Cool while continuing to stir, and at 40 ° C, add C and finish the preparation at about 35 ° C.
(処方例2)乳液
A、B共に80℃で加温溶解し、Aをホモミキサーで攪拌しながらBを徐々に加えて乳化する。攪拌を続けながら冷却し、40℃でCを加え、約35℃で調製を終了する。
(Prescription Example 2) Emulsion
Both A and B are heated and dissolved at 80 ° C., and B is gradually added and emulsified while A is stirred with a homomixer. Cool while continuing to stir, add C at 40 ° C. and finish the preparation at about 35 ° C.
(処方例3)化粧水
A、Bを室温で溶解する。Aを攪拌しながらBを加え調製を終了する。
(Formulation Example 3) Lotion
A and B are dissolved at room temperature. Add B while stirring A to complete the preparation.
(処方例4)シャンプー
Aを80℃で攪拌しながら均一に混合する。攪拌しながらBを加え、30℃まで冷却し自然脱泡させて作製する。
(Prescription Example 4) Shampoo
A is mixed uniformly at 80 ° C. with stirring. Add B while stirring, cool to 30 ° C., and degas naturally.
(処方例5)コンディショナー・トリートメント
水を80℃で攪拌しながら、上記処方例の表に記載の化合物を上から順番に加えて均一に混合した後30℃まで冷却して作製する。
(Formulation example 5) Conditioner treatment
While stirring water at 80 ° C., the compounds described in the table of the above formulation examples are added in order from the top and mixed uniformly, and then cooled to 30 ° C. to prepare.
本発明は黒砂糖エキスと小豆種皮抽出物を含有し、皮膚に潤いを与えるとともにしわやたるみ及び炎症を改善、予防し、しかも皮膚に対する安全性に優れたヒアルロニダーゼ阻害剤及び化粧料組成物を提供することができる。 The present invention provides a hyaluronidase inhibitor and cosmetic composition that contains brown sugar extract and red bean seed coat extract, moisturizes the skin, improves and prevents wrinkles, sagging and inflammation, and is excellent in skin safety. can do.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010086456A JP2011219365A (en) | 2010-04-02 | 2010-04-02 | Hyaluronidase inhibitor containing brown sugar extract and extract from red bean seed coat |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010086456A JP2011219365A (en) | 2010-04-02 | 2010-04-02 | Hyaluronidase inhibitor containing brown sugar extract and extract from red bean seed coat |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2011219365A true JP2011219365A (en) | 2011-11-04 |
Family
ID=45036805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010086456A Pending JP2011219365A (en) | 2010-04-02 | 2010-04-02 | Hyaluronidase inhibitor containing brown sugar extract and extract from red bean seed coat |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2011219365A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107961192A (en) * | 2011-12-19 | 2018-04-27 | 玫琳凯有限公司 | The purposes of composition comprising Semen Ormosiae Semicastratae extract |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001131047A (en) * | 1999-11-04 | 2001-05-15 | Rasheru Seiyaku Kk | Red bean extract-containing cosmetic composition |
| JP2002265324A (en) * | 2001-03-07 | 2002-09-18 | Ichimaru Pharcos Co Ltd | Cosmetic composition containing moisture retention plant extract |
| JP2003137766A (en) * | 2002-04-19 | 2003-05-14 | Noevir Co Ltd | Collagen production promoter for external use for skin, and hyaluronic acid production promoter for external use for skin |
| JP2004189698A (en) * | 2002-12-13 | 2004-07-08 | Nichirei Corp | Whitening agents, antioxidants, collagenase activity inhibitors, hyaluronidase activity inhibitors, anti-aging agents, skin external preparations, cosmetics and foodstuffs |
| JP2009114073A (en) * | 2007-11-01 | 2009-05-28 | Shiseido Co Ltd | Hyaluronidase inhibitor |
-
2010
- 2010-04-02 JP JP2010086456A patent/JP2011219365A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001131047A (en) * | 1999-11-04 | 2001-05-15 | Rasheru Seiyaku Kk | Red bean extract-containing cosmetic composition |
| JP2002265324A (en) * | 2001-03-07 | 2002-09-18 | Ichimaru Pharcos Co Ltd | Cosmetic composition containing moisture retention plant extract |
| JP2003137766A (en) * | 2002-04-19 | 2003-05-14 | Noevir Co Ltd | Collagen production promoter for external use for skin, and hyaluronic acid production promoter for external use for skin |
| JP2004189698A (en) * | 2002-12-13 | 2004-07-08 | Nichirei Corp | Whitening agents, antioxidants, collagenase activity inhibitors, hyaluronidase activity inhibitors, anti-aging agents, skin external preparations, cosmetics and foodstuffs |
| JP2009114073A (en) * | 2007-11-01 | 2009-05-28 | Shiseido Co Ltd | Hyaluronidase inhibitor |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107961192A (en) * | 2011-12-19 | 2018-04-27 | 玫琳凯有限公司 | The purposes of composition comprising Semen Ormosiae Semicastratae extract |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101975951B1 (en) | Manufacturing Method of Japanese Rose Flower Extract and Rose Flower Extract for Whitening Cosmetic Preparations containing these Extracts | |
| JP6919960B1 (en) | New phenylpropanoid compound | |
| US20110151031A1 (en) | Compositions and methods for utilizing the same | |
| JP2004300117A (en) | Cosmetic composition | |
| KR102055210B1 (en) | Aqueous solution of Ginsenoside Compound K and Manufacturing method thereof | |
| KR20100134323A (en) | Cosmetic composition for sebum suppression and acne improvement | |
| JP4813917B2 (en) | Skin cosmetics | |
| WO2022215441A1 (en) | Novel polyphenol compound | |
| JP2011219365A (en) | Hyaluronidase inhibitor containing brown sugar extract and extract from red bean seed coat | |
| JPH1029927A (en) | Antiaging agent | |
| KR20220112446A (en) | Composition for improving skin, comprising Rosa wichuraiana Extract as effective components, Cosmetic composition and Food functional composition including the same | |
| KR100513430B1 (en) | Cosmetic composition containing ginsan polysaccharide extracted from Panax ginseng | |
| KR20160016382A (en) | Skin External Composition Comprising the Niaouli | |
| EP3510991A1 (en) | Skin anti-aging composition containing dehydrogenated abietic acid and compound k | |
| KR20180055137A (en) | Composition comprising Rhus Semialata extract as active ingredient | |
| KR20190000175A (en) | Cosmetic composition for preventing uv-induced skin damage comprising the extract of solidago virgauea l. var coreana nakai | |
| KR102032969B1 (en) | Sun screen composition comprising Panax ginseng extract and Green tea extract | |
| KR102366234B1 (en) | Skin wrinkle improvement effects of solvent extracts from Desmodium sequax Wall or fractions thereof | |
| JP2000290131A (en) | Bleaching preparation | |
| KR101607593B1 (en) | Composition for Improving Skin Appearances | |
| KR102067698B1 (en) | Composition for skin-whitening and UV protection containing polysaccharides extracted from processed Panax ginseng and Green tea | |
| EP1721524A1 (en) | Antibacterial agent and antibacterial composition | |
| KR20210014864A (en) | Multi-functionalcosmetic composition using nature material | |
| KR102030679B1 (en) | Sun screen composition comprising Panax ginseng polysaccharide and Green tea polysaccharide | |
| JP2012136473A (en) | Hyaluronic acid production promoter |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130325 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20130717 |